Details for Patent: 9,050,348
✉ Email this page to a colleague
Which drugs does patent 9,050,348 protect, and when does it expire?
Patent 9,050,348 protects TWIRLA and is included in one NDA.
This patent has nineteen patent family members in twelve countries.
Summary for Patent: 9,050,348
| Title: | Dermal delivery device |
| Abstract: | A transdermal drug delivery device is disclosed. Over an extended wear period, the device causes cumulative moderate irritation plus significant irritation of less than 5% and/or achieves a meaningful degree of detachment over a seven day period of less than 20%. |
| Inventor(s): | Kydonieus; Agis (Kendall Park, NJ), Conway; Robert G. (Whitehouse Station, NJ), Rossi; Thomas M. (Stockton, NJ) |
| Assignee: | Agile Therapeutics, Inc. (Princeton, NJ) |
| Application Number: | 13/463,494 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; |
Drugs Protected by US Patent 9,050,348
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agile | TWIRLA | ethinyl estradiol; levonorgestrel | SYSTEM;TRANSDERMAL | 204017-001 | Feb 14, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,050,348
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008275101 | ⤷ Try a Trial | |||
| Brazil | PI0814697 | ⤷ Try a Trial | |||
| Canada | 2692884 | ⤷ Try a Trial | |||
| China | 101801321 | ⤷ Try a Trial | |||
| Eurasian Patent Organization | 020208 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
